Patents-Review.com
🔗 Permalink
Inventor profile of:

Christopher M. Starr

City:

Sonoma, California

Country:

United States

Published Applications:

24

Last publication date:

2020-06-18

Top Assignees for applications by Christopher M. Starr

The entities that hold a legal rights for patent applications filed by inventor Starr Christopher M.:

Recent patent applications by Starr Christopher M.

Christopher M. Starr from Sonoma, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2020-06-18
US20200188522A1
Human necessities

USE OF P97 AS AN ENZYME DELIVERY SYSTEM FOR THE DELIVERY OF THERAPEUTIC LYSOSOMAL ENZYMES

 #2 | 2018-05-03
US20180118802A1
Chemistry; metallurgy

COMPOSITIONS COMPRISING RECEPTOR-ASSOCIATED PROTEIN (RAP) VARIANTS SPECIFIC FOR CR-CONTAINING PROTEINS AND USES THEREOF

 #3 | 2018-01-25
US20180021445A1
Human necessities

Use of P97 as an enzyme delivery system for the delivery of therapeutic lysosomal enzymes

 #4 | 2016-01-28
US20160024172A1
Chemistry; metallurgy

Compositions comprising receptor-associated protein (RAP) variants specific for CR-containing proteins and uses thereof

 #5 | 2014-04-17
US20140105880A1
Human necessities

USE OF P97 AS AN ENZYME DELIVERY SYSTEM FOR THE DELIVERY OF THERAPEUTIC LYSOSOMAL ENZYMES

 #6 | 2012-10-04
US20120251444A1
Human necessities

Treatment of liver disorders by administration of RAP conjugates

 #7 | 2011-06-16
US20110142763A1
Chemistry; metallurgy

Megalin-based delivery of therapeutic compounds to the brain and other tissues

 #8 | 2010-12-02
US20100303797A1
Human necessities

Use of p97 as an enzyme delivery system for the delivery of therapeutic lysosomal enzymes

 #9 | 2010-08-19
US20100210517A1
Chemistry; metallurgy

Cyclic receptor-associated protein (RAP) peptides

 #10 | 2010-02-04
US20100028370A1
Chemistry; metallurgy

Receptor associated protein (RAP) conjugates

 #11 | 2009-11-12
US20090281024A1
Chemistry; metallurgy

Compositions comprising receptor-associated protein (RAP) variants specific for CR-containing proteins and uses thereof

 #12 | 2009-10-29
US20090269346A1
Chemistry; metallurgy

Compositions comprising receptor-associated protein (RAP) variants specific for LRP2 and uses thereof

 #13 | 2009-07-30
US20090191178A1
Chemistry; metallurgy

Manufacture of Highly Phosphorylated Lysosomal Enzymes and Uses Thereof

 #14 | 2008-10-23
US20080260715A1
Performing operations; transporting

Precursor N-acetylgalactosamine-4 sulfatase, methods of treatment using said enzyme and methods for producing and purifying said enzyme

 #15 | 2008-01-17
US20080014188A1
Chemistry; metallurgy

Manufacture of Highly Phosphorylated Lysosomal Enzymes and Uses Thereof

 #16 | 2006-02-23
US20060040348A1
Chemistry; metallurgy

Methods for producing and purifying recombinant alpha-L-iduronidase

 #17 | 2006-02-09
US20060029609A1
Chemistry; metallurgy

Methods of increasing delivery of active agents to brain comprising administering receptor associated protein (RAP) fragments conjugated to active agents

 #18 | 2005-12-29
US20050287133A1
Performing operations; transporting

Precursor N-acetylgalactosamine-4 sulfatase, methods of treatment using said enzyme and methods for producing and purifying said enzyme

 #19 | 2005-12-06
US10704365
-

Precursor of N-acetylgalactosamine-4-sulfatase, methods of treatment using said enzyme and methods for producing and purifying said enzyme

 #20 | 2005-07-21
US20050158296A1
Human necessities

Use of p97 as an enzyme delivery system for the delivery of therapeutic lysosomal enzymes

 #21 | 2005-05-12
US20050100539A1
Human necessities

Enzymes useful for treating and methods for treating MPS-VI and cells lines for producing such enzymes recombinantly

 #22 | 2005-03-15
US10290908
-

Precursor N-acetylgalactosamine-4-sulfatase, methods of treatment using said enzyme and methods for producing and purifying said enzyme

 #23 | 2005-02-24
US20050042227A1
Chemistry; metallurgy

Methods of increasing delivery of active agents to brain comprising administering receptor associated protein (RAP) fragments conjugated to active agents

 #24 | 2005-02-03
US20050026823A1
Chemistry; metallurgy

Use of the chaperone receptor-associated protein (RAP) for the delivery of therapeutic compounds to the brain and other tissues
InventorID:

727061 ⎘